BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Today GordonMD® Global Investments LP, a global alternative investment firm, is pleased to announce the hiring of Roxanne Bongiovanni-Blasucci as its Chief Operating Officer. Bongiovanni-Blasucci has over 20 years of experience, previously serving as CFO/CCO at Sancus Capital Management LP, Controller/Senior VP within Citibank Alternative Investments, and Assistant Controller at Credit Suisse First Boston LLC.
“Roxanne is a highly accomplished industry executive, and we’re delighted to welcome her to our team,” said Craig Gordon, MD, Founder, CEO, and CIO of GordonMD Global Investments. “As we move into the firm’s second year, her addition will further strengthen our operational and compliance infrastructure.”
“I am thrilled to join GordonMD Global Investments as Chief Operating Officer. I look forward to leading the firm’s operational activities, and working with my new colleagues to serve our accredited and institutional investor clients,” said Roxanne Bongiovanni-Blasucci.
- Craig Gordon, MD and Founder, CEO, and CIO
- Roxanne Bongiovanni-Blasucci, COO
- Andrew Yuen, Research Analyst
- Anthony Makdessi, Research Associate
- Ashley Thomas, Associate
GordonMD® Global Investments LP was founded in 2021 by Craig Gordon, MD, a licensed physician with 10+ years of buy-side experience managing global biopharmaceutical portfolios. The firm manages a private fund and a public fund, each focused on differentiated investment opportunities in biopharmaceutical companies primarily located in the U.S., Europe and Japan.
THIS PRESS RELEASE IS INTENDED FOR INFORMATIONAL PURPOSES ONLY. THIS IS NOT AN OFFER OR SOLICITATION WITH RESPECT TO THE PURCHASE OR SALE OF ANY FUND OR SECURITY.